位置:首页 > 蛋白库 > ENVZ_ECOLI
ENVZ_ECOLI
ID   ENVZ_ECOLI              Reviewed;         450 AA.
AC   P0AEJ4; P02933; Q2M769;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   20-DEC-2005, sequence version 1.
DT   03-AUG-2022, entry version 143.
DE   RecName: Full=Sensor histidine kinase EnvZ {ECO:0000305};
DE            EC=2.7.13.3 {ECO:0000269|PubMed:2668953};
DE   AltName: Full=Osmolarity sensor protein EnvZ {ECO:0000305};
GN   Name=envZ; Synonyms=ompB, perA, tpo; OrderedLocusNames=b3404, JW3367;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND OPERON STRUCTURE.
RX   PubMed=6292200; DOI=10.1016/s0021-9258(18)33502-6;
RA   Mizuno T., Wurtzel E.T., Inouye M.;
RT   "Osmoregulation of gene expression. II. DNA sequence of the envZ gene of
RT   the ompB operon of Escherichia coli and characterization of its gene
RT   product.";
RL   J. Biol. Chem. 257:13692-13698(1982).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], OPERON STRUCTURE, AND SEQUENCE REVISION
RP   TO N-TERMINUS.
RC   STRAIN=K12;
RX   PubMed=2997120; DOI=10.1128/jb.164.2.578-584.1985;
RA   Comeau D.E., Ikenaka K., Tsung K., Inouye M.;
RT   "Primary characterization of the protein products of the Escherichia coli
RT   ompB locus: structure and regulation of synthesis of the OmpR and EnvZ
RT   proteins.";
RL   J. Bacteriol. 164:578-584(1985).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J., Mau B.,
RA   Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains MG1655
RT   and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [5]
RP   FUNCTION, AND MUTAGENESIS OF THR-247.
RX   PubMed=3536870; DOI=10.1128/jb.168.3.1309-1314.1986;
RA   Matsuyama S., Mizuno T., Mizushima S.;
RT   "Interaction between two regulatory proteins in osmoregulatory expression
RT   of ompF and ompC genes in Escherichia coli: a novel ompR mutation
RT   suppresses pleiotropic defects caused by an envZ mutation.";
RL   J. Bacteriol. 168:1309-1314(1986).
RN   [6]
RP   SUBCELLULAR LOCATION, AND TOPOLOGY.
RX   PubMed=2824492; DOI=10.1016/s0021-9258(18)49274-5;
RA   Forst S., Comeau D., Norioka S., Inouye M.;
RT   "Localization and membrane topology of EnvZ, a protein involved in
RT   osmoregulation of OmpF and OmpC in Escherichia coli.";
RL   J. Biol. Chem. 262:16433-16438(1987).
RN   [7]
RP   PHOSPHORYLATION, DISRUPTION PHENOTYPE, AND MUTAGENESIS OF 1-MET--ALA-38.
RX   PubMed=3056929; DOI=10.1128/jb.170.12.5971-5973.1988;
RA   Igo M.M., Silhavy T.J.;
RT   "EnvZ, a transmembrane environmental sensor of Escherichia coli K-12, is
RT   phosphorylated in vitro.";
RL   J. Bacteriol. 170:5971-5973(1988).
RN   [8]
RP   FUNCTION IN PHOSPHORYLATING OMPR, CATALYTIC ACTIVITY, AND
RP   AUTOPHOSPHORYLATION.
RX   PubMed=2656684; DOI=10.1016/s0021-9258(18)81828-2;
RA   Aiba H., Mizuno T., Mizushima S.;
RT   "Transfer of phosphoryl group between two regulatory proteins involved in
RT   osmoregulatory expression of the ompF and ompC genes in Escherichia coli.";
RL   J. Biol. Chem. 264:8563-8567(1989).
RN   [9]
RP   FUNCTION IN PHOSPHORYLATING AND DEPHOSPHORYLATING OMPR, CATALYTIC ACTIVITY,
RP   AUTOPHOSPHORYLATION, AND MUTAGENESIS OF THR-247.
RX   PubMed=2668281; DOI=10.1016/s0021-9258(18)71647-5;
RA   Aiba H., Nakasai F., Mizushima S., Mizuno T.;
RT   "Evidence for the physiological importance of the phosphotransfer between
RT   the two regulatory components, EnvZ and OmpR, in osmoregulation in
RT   Escherichia coli.";
RL   J. Biol. Chem. 264:14090-14094(1989).
RN   [10]
RP   FUNCTION IN PHOSPHORYLATING OMPR, CATALYTIC ACTIVITY, AUTOPHOSPHORYLATION,
RP   AND MUTAGENESIS OF HIS-243.
RX   PubMed=2668953; DOI=10.1073/pnas.86.16.6052;
RA   Forst S., Delgado J., Inouye M.;
RT   "Phosphorylation of OmpR by the osmosensor EnvZ modulates expression of the
RT   ompF and ompC genes in Escherichia coli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:6052-6056(1989).
RN   [11]
RP   FUNCTION, CATALYTIC ACTIVITY, AND PHOSPHORYLATION.
RX   PubMed=2674113; DOI=10.1093/oxfordjournals.jbchem.a122817;
RA   Aiba H., Nakasai F., Mizushima S., Mizuno T.;
RT   "Phosphorylation of a bacterial activator protein, OmpR, by a protein
RT   kinase, EnvZ, results in stimulation of its DNA-binding ability.";
RL   J. Biochem. 106:5-7(1989).
RN   [12]
RP   FUNCTION IN PHOSPHORYLATING AND DEPHOSPHORYLATING OMPR, CROSSTALK BETWEEN
RP   TWO-COMPONENT SYSTEMS, AND MUTAGENESIS OF 1-MET--ALA-38.
RX   PubMed=2558046; DOI=10.1101/gad.3.11.1725;
RA   Igo M.M., Ninfa A.J., Stock J.B., Silhavy T.J.;
RT   "Phosphorylation and dephosphorylation of a bacterial transcriptional
RT   activator by a transmembrane receptor.";
RL   Genes Dev. 3:1725-1734(1989).
RN   [13]
RP   FUNCTION IN PHOSPHORYLATING AND DEPHOSPHORYLATING OMPR,
RP   AUTOPHOSPHORYLATION, DISRUPTION PHENOTYPE, AND MUTAGENESIS OF HIS-243.
RX   PubMed=2277041; DOI=10.1093/oxfordjournals.jbchem.a123225;
RA   Kanamaru K., Aiba H., Mizuno T.;
RT   "Transmembrane signal transduction and osmoregulation in Escherichia coli:
RT   I. Analysis by site-directed mutagenesis of the amino acid residues
RT   involved in phosphotransfer between the two regulatory components, EnvZ and
RT   OmpR.";
RL   J. Biochem. 108:483-487(1990).
RN   [14]
RP   FUNCTION IN PHOSPHORYLATING AND DEPHOSPHORYLATING OMPR, SUBCELLULAR
RP   LOCATION, AND MUTAGENESIS OF LEU-18; PRO-41; ARG-180; PRO-185 AND THR-247.
RX   PubMed=1323560; DOI=10.1093/oxfordjournals.jbchem.a123823;
RA   Tokishita S., Kojima A., Mizuno T.;
RT   "Transmembrane signal transduction and osmoregulation in Escherichia coli:
RT   functional importance of the transmembrane regions of membrane-located
RT   protein kinase, EnvZ.";
RL   J. Biochem. 111:707-713(1992).
RN   [15]
RP   PHOSPHORYLATION AT HIS-243.
RX   PubMed=8132603; DOI=10.1016/s0021-9258(17)37029-1;
RA   Roberts D.L., Bennett D.W., Forst S.A.;
RT   "Identification of the site of phosphorylation on the osmosensor, EnvZ, of
RT   Escherichia coli.";
RL   J. Biol. Chem. 269:8728-8733(1994).
RN   [16]
RP   SUBCELLULAR LOCATION, AND TOPOLOGY [LARGE SCALE ANALYSIS].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=15919996; DOI=10.1126/science.1109730;
RA   Daley D.O., Rapp M., Granseth E., Melen K., Drew D., von Heijne G.;
RT   "Global topology analysis of the Escherichia coli inner membrane
RT   proteome.";
RL   Science 308:1321-1323(2005).
RN   [17]
RP   SUBUNIT.
RX   PubMed=15357641; DOI=10.1042/bj20041125;
RA   Khorchid A., Inouye M., Ikura M.;
RT   "Structural characterization of Escherichia coli sensor histidine kinase
RT   EnvZ: the periplasmic C-terminal core domain is critical for
RT   homodimerization.";
RL   Biochem. J. 385:255-264(2005).
RN   [18]
RP   DOMAIN, AND MUTAGENESIS OF ALA-193.
RX   PubMed=17635923; DOI=10.1074/jbc.m701342200;
RA   Kishii R., Falzon L., Yoshida T., Kobayashi H., Inouye M.;
RT   "Structural and functional studies of the HAMP domain of EnvZ, an
RT   osmosensing transmembrane histidine kinase in Escherichia coli.";
RL   J. Biol. Chem. 282:26401-26408(2007).
RN   [19]
RP   INTERACTION WITH MZRA, AND ACTIVITY REGULATION.
RC   STRAIN=K12 / MC4100 / ATCC 35695 / DSM 6574;
RX   PubMed=19432797; DOI=10.1111/j.1365-2958.2009.06728.x;
RA   Gerken H., Charlson E.S., Cicirelli E.M., Kenney L.J., Misra R.;
RT   "MzrA: a novel modulator of the EnvZ/OmpR two-component regulon.";
RL   Mol. Microbiol. 72:1408-1422(2009).
RN   [20]
RP   INTERACTION WITH MZRA, AND ACTIVITY REGULATION.
RC   STRAIN=K12 / MC4100 / ATCC 35695 / DSM 6574;
RX   PubMed=20889743; DOI=10.1128/jb.00855-10;
RA   Gerken H., Misra R.;
RT   "MzrA-EnvZ interactions in the periplasm influence the EnvZ/OmpR two-
RT   component regulon.";
RL   J. Bacteriol. 192:6271-6278(2010).
RN   [21]
RP   MECHANISM, DOMAIN, AND AUTOPHOSPHORYLATION.
RX   PubMed=22543870; DOI=10.1038/emboj.2012.99;
RA   Wang L.C., Morgan L.K., Godakumbura P., Kenney L.J., Anand G.S.;
RT   "The inner membrane histidine kinase EnvZ senses osmolality via helix-coil
RT   transitions in the cytoplasm.";
RL   EMBO J. 31:2648-2659(2012).
RN   [22]
RP   ERRATUM OF PUBMED:22543870.
RX   PubMed=26427760; DOI=10.15252/embj.201592753;
RA   Wang L.C., Morgan L.K., Godakumbura P., Kenney L.J., Anand G.S.;
RT   "The inner membrane histidine kinase EnvZ senses osmolality via helix-coil
RT   transitions in the cytoplasm.";
RL   EMBO J. 34:2481-2481(2015).
RN   [23]
RP   MECHANISM, AND SUBUNIT.
RX   PubMed=28256224; DOI=10.1016/j.bpj.2016.12.027;
RA   Ghosh M., Wang L.C., Ramesh R., Morgan L.K., Kenney L.J., Anand G.S.;
RT   "Lipid-mediated regulation of embedded receptor kinases via parallel
RT   allosteric relays.";
RL   Biophys. J. 112:643-654(2017).
RN   [24]
RP   FUNCTION IN ACID STRESS.
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=29138484; DOI=10.1038/s41467-017-02030-0;
RA   Chakraborty S., Winardhi R.S., Morgan L.K., Yan J., Kenney L.J.;
RT   "Non-canonical activation of OmpR drives acid and osmotic stress responses
RT   in single bacterial cells.";
RL   Nat. Commun. 8:1587-1587(2017).
RN   [25]
RP   INTERACTION WITH MZRA, SUBUNIT, AND MUTAGENESIS OF 73-PRO-PRO-74 AND
RP   202-PRO--PRO-204.
RX   PubMed=29953503; DOI=10.1371/journal.pone.0199782;
RA   Motz M., Jung K.;
RT   "The role of polyproline motifs in the histidine kinase EnvZ.";
RL   PLoS ONE 13:E0199782-E0199782(2018).
RN   [26] {ECO:0007744|PDB:1BXD}
RP   STRUCTURE BY NMR OF 290-450 IN COMPLEX WITH ATP ANALOG, MUTAGENESIS OF
RP   ASN-347, AND AUTOPHOSPHORYLATION.
RX   PubMed=9817206; DOI=10.1038/23968;
RA   Tanaka T., Saha S.K., Tomomori C., Ishima R., Liu D., Tong K.I., Park H.,
RA   Dutta R., Qin L., Swindells M.B., Yamazaki T., Ono A.M., Kainosho M.,
RA   Inouye M., Ikura M.;
RT   "NMR structure of the histidine kinase domain of the E. coli osmosensor
RT   EnvZ.";
RL   Nature 396:88-92(1998).
RN   [27] {ECO:0007744|PDB:1JOY}
RP   STRUCTURE BY NMR OF 223-289, AND SUBUNIT.
RX   PubMed=10426948; DOI=10.1038/11495;
RA   Tomomori C., Tanaka T., Dutta R., Park H., Saha S.K., Zhu Y., Ishima R.,
RA   Liu D., Tong K.I., Kurokawa H., Qian H., Inouye M., Ikura M.;
RT   "Solution structure of the homodimeric core domain of Escherichia coli
RT   histidine kinase EnvZ.";
RL   Nat. Struct. Biol. 6:729-734(1999).
RN   [28]
RP   3D-STRUCTURE MODELING OF 223-450, AND TOPOLOGY.
RX   PubMed=12691749; DOI=10.1016/s0022-2836(03)00275-4;
RA   Cai S./J., Khorchid A., Ikura M., Inouye M.;
RT   "Probing catalytically essential domain orientation in histidine kinase
RT   EnvZ by targeted disulfide crosslinking.";
RL   J. Mol. Biol. 328:409-418(2003).
RN   [29] {ECO:0007744|PDB:5XGA}
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 36-158 IN THE PRESENCE OF
RP   DETERGENT, ACTIVITY REGULATION, AND DOMAIN.
RC   STRAIN=K12 / MC4100;
RX   PubMed=28423182; DOI=10.1002/1873-3468.12658;
RA   Hwang E., Cheong H.K., Kim S.Y., Kwon O., Blain K.Y., Choe S., Yeo K.J.,
RA   Jung Y.W., Jeon Y.H., Cheong C.;
RT   "Crystal structure of the EnvZ periplasmic domain with CHAPS.";
RL   FEBS Lett. 591:1419-1428(2017).
RN   [30] {ECO:0007744|PDB:5B1N, ECO:0007744|PDB:5B1O}
RP   X-RAY CRYSTALLOGRAPHY (1.33 ANGSTROMS) OF 223-289, X-RAY CRYSTALLOGRAPHY
RP   (2.30 ANGSTROMS) OF MUTATED 223-289, ACTIVITY REGULATION, SUBUNIT, DOMAIN,
RP   AND MUTAGENESIS OF ARG-234; SER-242; ASP-244; THR-247 AND PRO-248.
RX   PubMed=27999439; DOI=10.1038/ja.2016.151;
RA   Eguchi Y., Okajima T., Tochio N., Inukai Y., Shimizu R., Ueda S.,
RA   Shinya S., Kigawa T., Fukamizo T., Igarashi M., Utsumi R.;
RT   "Angucycline antibiotic waldiomycin recognizes common structural motif
RT   conserved in bacterial histidine kinases.";
RL   J. Antibiot. 70:251-258(2017).
CC   -!- FUNCTION: Member of the two-component regulatory system EnvZ/OmpR
CC       involved in osmoregulation (particularly of genes ompF and ompC) as
CC       well as other genes (PubMed:2997120, PubMed:3536870). EnvZ functions as
CC       a membrane-associated protein kinase that phosphorylates OmpR in
CC       response to environmental signals; at low osmolarity OmpR activates
CC       ompF transcription, while at high osmolarity it represses ompF and
CC       activates ompC transcription (PubMed:2656684, PubMed:2668281,
CC       PubMed:2668953, PubMed:2674113, PubMed:2558046, PubMed:2277041,
CC       PubMed:1323560). Also dephosphorylates OmpR in the presence of ATP
CC       (PubMed:2668281, PubMed:2558046, PubMed:2277041, PubMed:1323560). The
CC       cytoplasmic dimerization domain (CDD) forms an osmosensitive core;
CC       increasing osmolarity stabilizes this segment (possibly by its
CC       contraction), enhancing the autophosphorylation rate and consequently,
CC       downstream phosphotransfer to OmpR and signaling (PubMed:22543870,
CC       PubMed:28256224). Autophosphorylation is greater when full-length EnvZ
CC       is reconstituted in a lipid environment, lipid-mediated allostery
CC       impacts the kinase function of EnvZ (PubMed:28256224). Involved in acid
CC       stress response; this requires EnvZ but not OmpR phosphorylation, and
CC       suggests that EnvZ senses cytoplasmic acidic pH (PubMed:29138484).
CC       {ECO:0000269|PubMed:1323560, ECO:0000269|PubMed:22543870,
CC       ECO:0000269|PubMed:2277041, ECO:0000269|PubMed:2558046,
CC       ECO:0000269|PubMed:2656684, ECO:0000269|PubMed:2668281,
CC       ECO:0000269|PubMed:2668953, ECO:0000269|PubMed:2674113,
CC       ECO:0000269|PubMed:28256224, ECO:0000269|PubMed:29138484,
CC       ECO:0000269|PubMed:2997120, ECO:0000269|PubMed:3536870}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + protein L-histidine = ADP + protein N-phospho-L-
CC         histidine.; EC=2.7.13.3; Evidence={ECO:0000269|PubMed:2668953,
CC         ECO:0000305|PubMed:2656684, ECO:0000305|PubMed:2668281,
CC         ECO:0000305|PubMed:2674113};
CC   -!- ACTIVITY REGULATION: Activity is modulated by MzrA (PubMed:19432797,
CC       PubMed:20889743). In the presence of 0.2 M NaCl, 2.0 mM sodium cholate
CC       (bile salts) decreases expression from the ompC promoter; how this is
CC       mediated is unknown (PubMed:28423182). Autophosphorylation is inhibited
CC       by the angucycline antibiotic waldiomycin in a non-competitive manner;
CC       waldiomycin prevents dimerization of the cytoplasmic domain and
CC       autophosphorylation (PubMed:27999439). {ECO:0000269|PubMed:19432797,
CC       ECO:0000269|PubMed:20889743, ECO:0000269|PubMed:27999439,
CC       ECO:0000269|PubMed:28423182}.
CC   -!- SUBUNIT: Homodimer (PubMed:10426948, PubMed:15357641, PubMed:9817206,
CC       PubMed:28256224, PubMed:29953503, PubMed:27999439). Interacts with MzrA
CC       (PubMed:19432797, PubMed:20889743, PubMed:29953503).
CC       {ECO:0000269|PubMed:10426948, ECO:0000269|PubMed:15357641,
CC       ECO:0000269|PubMed:19432797, ECO:0000269|PubMed:20889743,
CC       ECO:0000269|PubMed:27999439, ECO:0000269|PubMed:28256224,
CC       ECO:0000269|PubMed:29953503, ECO:0000269|PubMed:9817206}.
CC   -!- INTERACTION:
CC       P0AEJ4; P0AEJ4: envZ; NbExp=2; IntAct=EBI-1121750, EBI-1121750;
CC       P0AEJ4; P42615: mzrA; NbExp=3; IntAct=EBI-1121750, EBI-6412632;
CC       P0AEJ4; P0AA16: ompR; NbExp=2; IntAct=EBI-1121750, EBI-369514;
CC   -!- SUBCELLULAR LOCATION: Cell inner membrane {ECO:0000269|PubMed:1323560,
CC       ECO:0000269|PubMed:15919996, ECO:0000269|PubMed:2824492}; Multi-pass
CC       membrane protein {ECO:0000305|PubMed:1323560,
CC       ECO:0000305|PubMed:15919996, ECO:0000305|PubMed:2824492}.
CC   -!- INDUCTION: Part of the ompR-envZ operon. {ECO:0000305|PubMed:2997120,
CC       ECO:0000305|PubMed:6292200}.
CC   -!- DOMAIN: The periplasmic domain interacts with MzrA (PubMed:20889743)
CC       (Probable). The periplasmic domain assumes a PDC sensor fold
CC       (PubMed:28423182). The HAMP domain by itself is intrinsically
CC       disordered (PubMed:17635923). The cytoplasmic dimerization domain (CDD,
CC       residues 223-289) forms an osmosensitive core; increasing osmolarity
CC       stabilizes this segment, enhancing its autophosphorylation rate and
CC       consequently, downstream phosphotransfer to OmpR and signaling
CC       (PubMed:17635923, PubMed:28256224). The autophosphorylation activity of
CC       the CDD is inhibited by the angucycline antibiotic waldiomycin which
CC       probably binds to it (PubMed:27999439). The soluble EnvZ C-terminal
CC       fragment (residues 180-450) is capable of conferring osmolarity-
CC       sensitive expression of OmpC in the absence of the membrane anchor
CC       (PubMed:17635923). {ECO:0000269|PubMed:17635923,
CC       ECO:0000269|PubMed:20889743, ECO:0000269|PubMed:27999439,
CC       ECO:0000269|PubMed:28256224, ECO:0000269|PubMed:28423182,
CC       ECO:0000305|PubMed:19432797}.
CC   -!- PTM: Autophosphorylated (PubMed:3056929, PubMed:2656684,
CC       PubMed:2668281, PubMed:2668953, PubMed:8132603, PubMed:2277041).
CC       Incubation of isolated EnvZ C-terminal fragment (residues 180-450) with
CC       increasing levels of NaCl or sucrose increases its autophosphorylation
CC       (PubMed:17635923). {ECO:0000269|PubMed:17635923,
CC       ECO:0000269|PubMed:2277041, ECO:0000269|PubMed:2656684,
CC       ECO:0000269|PubMed:2668281, ECO:0000269|PubMed:2668953,
CC       ECO:0000269|PubMed:8132603, ECO:0000303|PubMed:3056929}.
CC   -!- DISRUPTION PHENOTYPE: No expression of OmpC or OmpF during growth at 0%
CC       sucrose, low expression of OmpF at 15% sucrose (PubMed:3056929). Single
CC       deletion of envZ has no OmpC or OmpF at 0% sucrose, low levels of OmpC
CC       and very low levels of OmpF at 15% sucrose. Deletion of both ompR and
CC       envZ leads to loss of both OmpC and OmpF expression at 0% and 15%
CC       sucrose (PubMed:2277041). {ECO:0000269|PubMed:2277041,
CC       ECO:0000269|PubMed:3056929}.
CC   -!- MISCELLANEOUS: Cross talk between this and the Che and Ntr two-
CC       component systems can occur at least in vitro.
CC       {ECO:0000269|PubMed:2558046}.
CC   -!- MISCELLANEOUS: Two or more proline residues often cause ribosome
CC       stalling and decreased protein translation; the cytoplasmic strong stop
CC       motif IPPPL does not have this effect and instead is involved in
CC       homodimerization, while the weaker periplasmic stop motif VVPPA motif
CC       is involved in MzrA interaction. {ECO:0000269|PubMed:29953503}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J01656; AAA16242.1; -; Unassigned_RNA.
DR   EMBL; U18997; AAA58201.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC76429.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAE77887.1; -; Genomic_DNA.
DR   PIR; B25024; MMECZB.
DR   RefSeq; NP_417863.1; NC_000913.3.
DR   RefSeq; WP_001253696.1; NZ_STEB01000004.1.
DR   PDB; 1BXD; NMR; -; A=290-450.
DR   PDB; 1JOY; NMR; -; A/B=223-289.
DR   PDB; 3ZCC; X-ray; 1.25 A; A/B=229-288.
DR   PDB; 3ZRV; X-ray; 1.65 A; A/B=229-290.
DR   PDB; 3ZRW; X-ray; 2.25 A; A/C/D=229-289, B=231-289.
DR   PDB; 3ZRX; X-ray; 1.25 A; A/B=229-289.
DR   PDB; 4CTI; X-ray; 2.85 A; A/B/C/D=228-450.
DR   PDB; 4KP4; X-ray; 3.00 A; A/B=223-253, A/B=266-450.
DR   PDB; 5B1N; X-ray; 1.33 A; A=223-289.
DR   PDB; 5B1O; X-ray; 2.30 A; A/B=223-289.
DR   PDB; 5XGA; X-ray; 1.95 A; A=36-158.
DR   PDBsum; 1BXD; -.
DR   PDBsum; 1JOY; -.
DR   PDBsum; 3ZCC; -.
DR   PDBsum; 3ZRV; -.
DR   PDBsum; 3ZRW; -.
DR   PDBsum; 3ZRX; -.
DR   PDBsum; 4CTI; -.
DR   PDBsum; 4KP4; -.
DR   PDBsum; 5B1N; -.
DR   PDBsum; 5B1O; -.
DR   PDBsum; 5XGA; -.
DR   AlphaFoldDB; P0AEJ4; -.
DR   SMR; P0AEJ4; -.
DR   BioGRID; 4261266; 47.
DR   DIP; DIP-48357N; -.
DR   IntAct; P0AEJ4; 5.
DR   MINT; P0AEJ4; -.
DR   STRING; 511145.b3404; -.
DR   DrugBank; DB04395; Phosphoaminophosphonic Acid-Adenylate Ester.
DR   iPTMnet; P0AEJ4; -.
DR   jPOST; P0AEJ4; -.
DR   PaxDb; P0AEJ4; -.
DR   PRIDE; P0AEJ4; -.
DR   EnsemblBacteria; AAC76429; AAC76429; b3404.
DR   EnsemblBacteria; BAE77887; BAE77887; BAE77887.
DR   GeneID; 66672714; -.
DR   GeneID; 947272; -.
DR   KEGG; ecj:JW3367; -.
DR   KEGG; eco:b3404; -.
DR   PATRIC; fig|1411691.4.peg.3325; -.
DR   EchoBASE; EB0265; -.
DR   eggNOG; COG2205; Bacteria.
DR   HOGENOM; CLU_000445_89_27_6; -.
DR   InParanoid; P0AEJ4; -.
DR   OMA; WIRPPQA; -.
DR   PhylomeDB; P0AEJ4; -.
DR   BioCyc; EcoCyc:ENVZ-MON; -.
DR   BioCyc; MetaCyc:ENVZ-MON; -.
DR   BRENDA; 2.7.13.3; 2026.
DR   EvolutionaryTrace; P0AEJ4; -.
DR   PRO; PR:P0AEJ4; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005829; C:cytosol; IDA:EcoCyc.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:EcoCyc.
DR   GO; GO:0030288; C:outer membrane-bounded periplasmic space; IDA:EcoCyc.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0004721; F:phosphoprotein phosphatase activity; IDA:EcoCyc.
DR   GO; GO:0000155; F:phosphorelay sensor kinase activity; IDA:EcoCyc.
DR   GO; GO:0018106; P:peptidyl-histidine phosphorylation; IDA:EcoCyc.
DR   GO; GO:0000160; P:phosphorelay signal transduction system; IDA:EcoliWiki.
DR   GO; GO:0016310; P:phosphorylation; IDA:EcoliWiki.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:EcoliWiki.
DR   GO; GO:0006470; P:protein dephosphorylation; IDA:EcoliWiki.
DR   GO; GO:0006970; P:response to osmotic stress; IDA:EcoCyc.
DR   GO; GO:0007165; P:signal transduction; IDA:EcoCyc.
DR   CDD; cd00082; HisKA; 1.
DR   Gene3D; 3.30.565.10; -; 1.
DR   InterPro; IPR003660; HAMP_dom.
DR   InterPro; IPR003594; HATPase_C.
DR   InterPro; IPR036890; HATPase_C_sf.
DR   InterPro; IPR005467; His_kinase_dom.
DR   InterPro; IPR003661; HisK_dim/P.
DR   InterPro; IPR036097; HisK_dim/P_sf.
DR   InterPro; IPR004358; Sig_transdc_His_kin-like_C.
DR   Pfam; PF00672; HAMP; 1.
DR   Pfam; PF02518; HATPase_c; 1.
DR   Pfam; PF00512; HisKA; 1.
DR   PRINTS; PR00344; BCTRLSENSOR.
DR   SMART; SM00304; HAMP; 1.
DR   SMART; SM00387; HATPase_c; 1.
DR   SMART; SM00388; HisKA; 1.
DR   SUPFAM; SSF47384; SSF47384; 1.
DR   SUPFAM; SSF55874; SSF55874; 1.
DR   PROSITE; PS50885; HAMP; 1.
DR   PROSITE; PS50109; HIS_KIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Cell inner membrane; Cell membrane; Kinase;
KW   Membrane; Nucleotide-binding; Phosphoprotein; Reference proteome;
KW   Stress response; Transferase; Transmembrane; Transmembrane helix;
KW   Two-component regulatory system.
FT   CHAIN           1..450
FT                   /note="Sensor histidine kinase EnvZ"
FT                   /id="PRO_0000074759"
FT   TOPO_DOM        1..15
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:2824492"
FT   TRANSMEM        16..35
FT                   /note="Helical"
FT                   /evidence="ECO:0000305|PubMed:2824492"
FT   TOPO_DOM        36..158
FT                   /note="Periplasmic"
FT                   /evidence="ECO:0000305|PubMed:2824492"
FT   TRANSMEM        159..179
FT                   /note="Helical"
FT                   /evidence="ECO:0000305|PubMed:2824492"
FT   TOPO_DOM        180..450
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:15919996,
FT                   ECO:0000305|PubMed:17635923, ECO:0000305|PubMed:2824492"
FT   DOMAIN          180..232
FT                   /note="HAMP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00102"
FT   DOMAIN          240..440
FT                   /note="Histidine kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00107"
FT   REGION          223..289
FT                   /note="Cytoplasmic dimerization domain (CDD), when
FT                   dimerized forms osmosensitive core"
FT                   /evidence="ECO:0000269|PubMed:17635923"
FT   MOTIF           71..75
FT                   /note="polyP-periplasmic motif"
FT                   /evidence="ECO:0000303|PubMed:29953503"
FT   MOTIF           201..205
FT                   /note="polyP-cytoplasmic motif"
FT                   /evidence="ECO:0000303|PubMed:29953503"
FT   BINDING         243
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0007744|PDB:4KP4"
FT   BINDING         347..351
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0007744|PDB:4KP4"
FT   BINDING         373
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0007744|PDB:4KP4"
FT   BINDING         392..393
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0007744|PDB:4KP4"
FT   BINDING         402..406
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0007744|PDB:4KP4"
FT   MOD_RES         243
FT                   /note="Phosphohistidine; by autocatalysis"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00107,
FT                   ECO:0000269|PubMed:8132603"
FT   MUTAGEN         1..38
FT                   /note="MRRLRFSPRSSFARTLLLIVTLLFASLVTTYLVVLNFA->MTMITDSL: In
FT                   envZ115; low constitutive expression of OmpC or OmpF at low
FT                   and high osmolarity. Phosphorylates and dephosphorylates
FT                   OmpR."
FT                   /evidence="ECO:0000269|PubMed:2558046,
FT                   ECO:0000269|PubMed:3056929"
FT   MUTAGEN         18
FT                   /note="L->F: No OmpC, constitutive OmpF, with or without
FT                   sucrose. No change in phosphorylation or dephosphorylation
FT                   of OmpR."
FT                   /evidence="ECO:0000269|PubMed:1323560"
FT   MUTAGEN         41
FT                   /note="P->L,S: Constitutive OmpC, no OmpF, with or without
FT                   sucrose. Phosphorylates but does not dephosphorylate OmpR."
FT                   /evidence="ECO:0000269|PubMed:1323560"
FT   MUTAGEN         73..74
FT                   /note="PP->AA: Decreased interaction with MzrA."
FT                   /evidence="ECO:0000269|PubMed:29953503"
FT   MUTAGEN         180
FT                   /note="R->C: No OmpC, constitutive OmpF, with or without
FT                   sucrose. Weakly phosphorylates OmpR, dephosphorylates
FT                   normally."
FT                   /evidence="ECO:0000269|PubMed:1323560"
FT   MUTAGEN         185
FT                   /note="P->L: Constitutive OmpC, no OmpF, with or without
FT                   sucrose. Weakly phosphorylates but does not dephosphorylate
FT                   OmpR."
FT                   /evidence="ECO:0000269|PubMed:1323560"
FT   MUTAGEN         193
FT                   /note="A->L: Promotes the formation of alpha-helical
FT                   secondary structure of the HAMP domain."
FT                   /evidence="ECO:0000269|PubMed:17635923"
FT   MUTAGEN         193
FT                   /note="A->V: No effect."
FT                   /evidence="ECO:0000269|PubMed:17635923"
FT   MUTAGEN         202..204
FT                   /note="PPP->AAA: Decreased protein homodimerization,
FT                   constitutive OmpC, little to no OmpF with or without salt,
FT                   no interaction with MzrA."
FT                   /evidence="ECO:0000269|PubMed:29953503"
FT   MUTAGEN         234
FT                   /note="R->A: Autophosphorylation by cytoplasmic
FT                   dimerization domain (CDD) is resistant to waldiomycin."
FT                   /evidence="ECO:0000269|PubMed:27999439"
FT   MUTAGEN         242
FT                   /note="S->A: Autophosphorylation by CDD is resistant to
FT                   waldiomycin, CDD peptide probably no longer binds
FT                   waldiomycin."
FT                   /evidence="ECO:0000269|PubMed:27999439"
FT   MUTAGEN         243
FT                   /note="H->R: Does not autophosphorylate, does not
FT                   dephosphorylate OmpR in vitro, no OmpC or OmpF at 0%
FT                   sucrose, low levels of OmpC and very low levels of OmpF at
FT                   15% sucrose."
FT                   /evidence="ECO:0000269|PubMed:2277041"
FT   MUTAGEN         243
FT                   /note="H->V: Does not autophosphorylate, does not transfer
FT                   phosphate to OmpR, increased expression of ompC, decreased
FT                   expression of OmpF."
FT                   /evidence="ECO:0000269|PubMed:2668953"
FT   MUTAGEN         244
FT                   /note="D->A: Autophosphorylation by CDD is resistant to
FT                   waldiomycin, CDD peptide probably no longer binds
FT                   waldiomycin."
FT                   /evidence="ECO:0000269|PubMed:27999439"
FT   MUTAGEN         247
FT                   /note="T->A: Autophosphorylation by CDD is somewhat
FT                   resistant to waldiomycin."
FT                   /evidence="ECO:0000269|PubMed:27999439"
FT   MUTAGEN         247
FT                   /note="T->R: In envZ11/MH1461; OmpF- OmpC constitutive.
FT                   Also prevents expression of PhoA and LamB. Phosphorylates
FT                   OmpR but does not dephosphorylate it."
FT                   /evidence="ECO:0000269|PubMed:1323560,
FT                   ECO:0000269|PubMed:2668281, ECO:0000269|PubMed:3536870"
FT   MUTAGEN         248
FT                   /note="P->A: Autophosphorylation by CDD is resistant to
FT                   waldiomycin, CDD peptide probably no longer binds
FT                   waldiomycin, alters structure."
FT                   /evidence="ECO:0000269|PubMed:27999439"
FT   MUTAGEN         347
FT                   /note="N->D: Loss of ATP binding; loss of
FT                   autophosphorylation."
FT                   /evidence="ECO:0000269|PubMed:9817206"
FT   HELIX           43..57
FT                   /evidence="ECO:0007829|PDB:5XGA"
FT   STRAND          60..63
FT                   /evidence="ECO:0007829|PDB:5XGA"
FT   STRAND          69..71
FT                   /evidence="ECO:0007829|PDB:5XGA"
FT   HELIX           74..84
FT                   /evidence="ECO:0007829|PDB:5XGA"
FT   STRAND          87..90
FT                   /evidence="ECO:0007829|PDB:5XGA"
FT   HELIX           91..97
FT                   /evidence="ECO:0007829|PDB:5XGA"
FT   HELIX           99..101
FT                   /evidence="ECO:0007829|PDB:5XGA"
FT   HELIX           106..116
FT                   /evidence="ECO:0007829|PDB:5XGA"
FT   STRAND          120..125
FT                   /evidence="ECO:0007829|PDB:5XGA"
FT   STRAND          132..137
FT                   /evidence="ECO:0007829|PDB:5XGA"
FT   STRAND          143..148
FT                   /evidence="ECO:0007829|PDB:5XGA"
FT   HELIX           229..257
FT                   /evidence="ECO:0007829|PDB:3ZCC"
FT   HELIX           261..263
FT                   /evidence="ECO:0007829|PDB:3ZCC"
FT   HELIX           264..287
FT                   /evidence="ECO:0007829|PDB:3ZCC"
FT   TURN            290..292
FT                   /evidence="ECO:0007829|PDB:4CTI"
FT   STRAND          297..299
FT                   /evidence="ECO:0007829|PDB:4CTI"
FT   HELIX           301..309
FT                   /evidence="ECO:0007829|PDB:4CTI"
FT   STRAND          314..316
FT                   /evidence="ECO:0007829|PDB:1BXD"
FT   STRAND          319..322
FT                   /evidence="ECO:0007829|PDB:4CTI"
FT   STRAND          329..332
FT                   /evidence="ECO:0007829|PDB:4KP4"
FT   HELIX           334..350
FT                   /evidence="ECO:0007829|PDB:4CTI"
FT   STRAND          352..354
FT                   /evidence="ECO:0007829|PDB:4KP4"
FT   STRAND          356..359
FT                   /evidence="ECO:0007829|PDB:4CTI"
FT   STRAND          369..373
FT                   /evidence="ECO:0007829|PDB:4CTI"
FT   STRAND          378..380
FT                   /evidence="ECO:0007829|PDB:4CTI"
FT   HELIX           383..386
FT                   /evidence="ECO:0007829|PDB:4KP4"
FT   HELIX           394..397
FT                   /evidence="ECO:0007829|PDB:4KP4"
FT   HELIX           402..415
FT                   /evidence="ECO:0007829|PDB:4CTI"
FT   STRAND          419..422
FT                   /evidence="ECO:0007829|PDB:4CTI"
FT   TURN            426..428
FT                   /evidence="ECO:0007829|PDB:1BXD"
FT   STRAND          431..435
FT                   /evidence="ECO:0007829|PDB:4CTI"
SQ   SEQUENCE   450 AA;  50334 MW;  D58444D038722146 CRC64;
     MRRLRFSPRS SFARTLLLIV TLLFASLVTT YLVVLNFAIL PSLQQFNKVL AYEVRMLMTD
     KLQLEDGTQL VVPPAFRREI YRELGISLYS NEAAEEAGLR WAQHYEFLSH QMAQQLGGPT
     EVRVEVNKSS PVVWLKTWLS PNIWVRVPLT EIHQGDFSPL FRYTLAIMLL AIGGAWLFIR
     IQNRPLVDLE HAALQVGKGI IPPPLREYGA SEVRSVTRAF NHMAAGVKQL ADDRTLLMAG
     VSHDLRTPLT RIRLATEMMS EQDGYLAESI NKDIEECNAI IEQFIDYLRT GQEMPMEMAD
     LNAVLGEVIA AESGYEREIE TALYPGSIEV KMHPLSIKRA VANMVVNAAR YGNGWIKVSS
     GTEPNRAWFQ VEDDGPGIAP EQRKHLFQPF VRGDSARTIS GTGLGLAIVQ RIVDNHNGML
     ELGTSERGGL SIRAWLPVPV TRAQGTTKEG
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024